Winners of 2024 DEI Employer® Awards. 2024 DEI Employer® Awards. 2024 DEI Employer® Awards & Top 100 DEI Employer® SHANGHAI, CHINA, January 6, 2025 /EI ...

Scientists comment on cases of Human Metapneumovirus (hMPV) reported in China. Prof Sir Andrew Pollard, Director of the Oxford Vaccine Group; Ashall Professor of Infection and Immunity; Pandemic ...

- Dan Monahan will lead the commercialization strategy across Amylyx’ product portfolio, beginning with avexitide, an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor ...

I-Mab has begun the new year with a pipeline pivot, pausing work on an asset that Sanofi bought into last year to focus on ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Hemophilia News Today compiled a summary of the 10 most read hemophilia stories of 2024, with links to the individual items.

China’s National Medical Products Administration (NMPA) has approved Nucala (mepolizumab), a monoclonal antibody from UK ...

GSK's Nucala gets China approval for chronic rhinosinusitis with nasal polyps; awaits FDA decision for COPD in May as it ...

In separate DLL3 antibody-drug conjugate (ADC) deals, Roche licensed from Innovent Biologics and Ideaya reached for Hengrui.

A new report from Renub Research forecasts that the diabetes device market in China will grow from US$6.22 billion in 2023 to US$12.74 billion by 2032, representing a compound annual growth rate (CAGR ...

In 2023, drug companies launched new medications at prices 35 percent higher than the year before. On January 1, Pfizer ...

DOVBLERON® was approved by China’s National Medical Products Administration (NMPA): 1) for the treatment of adult patients with locally advanced or metastatic ROS1-positive NSCLC who have previously ...